The U.S. Food and Drug Administration is seeking a permanent injunction against the California manufacturer of over-the-counter vaginal products because regulators say the products have not been approved for safety.
Washington, D.C.-based lawyers from the U.S. Department of Justice, Civil Division, filed the complaint for the FDA in California federal district court against Laclede Inc., of Rancho Dominguez, Los Angeles County, and Michael A. Pellico, the president, founder and 50-percent owner of Laclede.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
